WVE
Wave Life Sciences·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
WVE Profile
Wave Life Sciences Ltd.
A biotechnology company that develops and commercializes nucleic acid therapies for genetic diseases
Pharmaceutical
07/23/2012
11/11/2015
NASDAQ Stock Exchange
287
12-31
Common stock
7 Straits View #12-00, Marina One East Tower, Singapore 018936
--
Wave Life Sciences Ltd., was incorporated in Singapore on July 23, 2012.
The company is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA drugs (also known as oligonucleotides) or targeted ribonucleic acids (" RNA ") to transform human health. The company's RNA drug platform, PRISMTM, combines multiple models, chemical innovations and insights into human genetics to provide scientific breakthroughs in the treatment of rare and endemic diseases. The Company's RNA Targeting Pattern Toolkit, which includes RNA editing, splicing, antisense silencing and RNA interference (" RNAi "), provides the Company with a unique capability to design and sustainably deliver drug candidates that best address disease biology. The Company leads projects involving rare and prevalent diseases including α-1 antitrypsin deficiency (" AATD "), obesity, Duchenne muscular dystrophy (" DMD ") and Huntington's disease (" HD ").
